SEC Form 4 · accession 0001144204-15-041150
Alliqua BioMedical, Inc. · ALQA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ian Johnson
Officer — President and CEO · Director
Period of report
Jul 1, 2015
Accepted (ET)
Jul 6, 2015 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054274
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 1, 2015 | F | 19,191 | $5.35 | D | 575,953 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock withheld to pay Mr. Johnson's tax withholding obligations incurred in connection with the vesting of 46,175 shares of restricted stock on July 1, 2015.